Kcm Investment Advisors LLC Corcept Therapeutics Inc Transaction History

Kcm Investment Advisors LLC

$2.91 Billion
Q3 2024

A detailed history of Kcm Investment Advisors LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 57,426 shares of CORT stock, worth $3.84 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

57,426

Previous 57,426 -0.0%

Holding current value

$3.84 Million

Previous $1.87 Million 42.41%

% of portfolio

0.09%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$22.21 - $34.48 $4,442 - $6,895	200 Added 0.35%	57,426 $1.87 Million
Q1 2024 May 07, 2024	BUY	$21.1 - $27.46 $84,948 - $110,553	4,026 Added 7.57%	57,226 $1.44 Million
Q4 2023 Feb 13, 2024	SELL	$24.82 - $32.88 $4,964 - $6,576	-200 Reduced 0.37%	53,200 $1.73 Million
Q3 2023 Nov 08, 2023	SELL	$21.97 - $33.8 $1.41 Million - $2.17 Million	-64,157 Reduced 54.58%	53,400 $1.46 Million
Q2 2023 Aug 09, 2023	BUY	$21.44 - $25.15 $914,115 - $1.07 Million	42,636 Added 56.91%	117,557 $2.62 Million
Q1 2023 May 09, 2023	BUY	$19.2 - $24.47 $141,734 - $180,637	7,382 Added 10.93%	74,921 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $55,144 - $80,504	3,182 Added 4.94%	67,539 $1.61 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $66,120 - $100,840	-4,000 Reduced 5.85%	64,357 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $108,756 - $148,442	-6,360 Reduced 8.51%	68,357 $1.35 Million
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $681,479 - $780,168	34,628 Added 86.38%	74,717 $1.47 Million
Q1 2021 May 13, 2021	BUY	$23.49 - $30.56 $4,698 - $6,112	200 Added 0.5%	40,089 $954,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $438,779 - $728,373	39,889 New	39,889 $671,000

Others Institutions Holding CORT

# of Institutions

355

Shares Held

86.2M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Account

Kcm Investment Advisors LLC Corcept Therapeutics Inc Transaction History